financetom
Business
financetom
/
Business
/
White House explores rules that would upend shareholder voting, WSJ reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
White House explores rules that would upend shareholder voting, WSJ reports
Nov 12, 2025 4:51 AM

(Reuters) -The White House is exploring new measures to curb the influence of proxy advisers and index-fund managers, the Wall Street Journal reported on Wednesday citing people familiar with the matter.

Trump administration officials are discussing at least one executive order that would restrict proxy-advisory firms such as Institutional Shareholder Services and Glass Lewis, the Journal's report added.

Officials are also exploring limits on how index-fund managers are allowed to vote, the report said.

"As a registered investment advisor that has been subject to oversight by the SEC for a quarter of a century, ISS is committed to fulfilling its fiduciary duties to clients and operating in a transparent and ethical manner," an ISS spokesperson said in an emailed statement to Reuters.

Representatives for the White House and Glass Lewis did not immediately respond to Reuters' requests for comment. Reuters could not independently verify the report.

Glass Lewis and ISS, the two largest U.S. proxy advisory firms, analyze shareholder proposals and corporate governance issues and provide voting recommendations to institutional investors ahead of annual meetings.

Both firms have long drawn criticism for their influential voting recommendations, traditionally from corporate executives, but their guidance remains widely used by institutional investors.

Meanwhile, index-fund managers such as Vanguard, BlackRock and State Street also manage and own the stock of some of the biggest U.S. publicly traded companies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MOVES-Citi names Lee Lung Nien as Singapore country officer and banking head
MOVES-Citi names Lee Lung Nien as Singapore country officer and banking head
Sep 15, 2025
SINGAPORE, Sept 15 (Reuters) - Citigroup ( C/PN ) has appointed Lee Lung Nien as its Citi Country Officer and Banking Head for Singapore, the U.S. bank said in a statement on Monday. Lee, a 35-year Citi veteran and most recently chairman of Citi Private Bank for South Asia since 2020, will take up the role on Oct. 6, reporting...
Ares Management Insider Sold Shares Worth $22,971,970, According to a Recent SEC Filing
Ares Management Insider Sold Shares Worth $22,971,970, According to a Recent SEC Filing
Sep 15, 2025
03:36 AM EDT, 09/15/2025 (MT Newswires) -- Antony P Ressler, 10% Owner, Director, Co-Founder & Executive Chairman, on September 10, 2025, sold 128,837 shares in Ares Management ( ARES ) for $22,971,970. Following the Form 4 filing with the SEC, Ressler has control over a total of 2,235,625 Class A common shares of the company, with 2,235,625 controlled indirectly. SEC...
Ares Management Insider Sold Shares Worth $3,746,321, According to a Recent SEC Filing
Ares Management Insider Sold Shares Worth $3,746,321, According to a Recent SEC Filing
Sep 15, 2025
03:38 AM EDT, 09/15/2025 (MT Newswires) -- Aghili Naseem Sagati, General Counsel, on September 10, 2025, sold 21,000 shares in Ares Management ( ARES ) for $3,746,321. Following the Form 4 filing with the SEC, Sagati has control over a total of 276,397 Class A common shares of the company, with 276,397 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1176948/000177901425000004/xslF345X05/wk-form4_1757720040.xml ...
Pulse Biosciences Insider Bought Shares Worth $2,788,624, According to a Recent SEC Filing
Pulse Biosciences Insider Bought Shares Worth $2,788,624, According to a Recent SEC Filing
Sep 15, 2025
03:34 AM EDT, 09/15/2025 (MT Newswires) -- Robert W Duggan, 10% Owner, Director, on September 10, 2025, executed a purchase for 192,599 shares in Pulse Biosciences ( PLSE ) for $2,788,624. Following the Form 4 filing with the SEC, Duggan has control over a total of 48,789,438 common shares of the company, with 47,709,140 shares held directly and 1,080,298 controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved